Biggest News Aggregation in the World
📰 Pharma Inc News

Page 2 - Pharma Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pharma Inc. Real-time updates on events, politics, business and more.

FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest

TORONTO, ON / ACCESSWIRE / May 31, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to
United States New York Raza Bokhari Zeeshan Saeed Company Annual Report On Form Drug Administration

Acasti Pharma (NASDAQ:ACST) Stock Passes Below 200-Day Moving Average of $2.79

Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $2.79 and traded as low as $2.63. Acasti Pharma shares last traded at $2.72, with a volume of 13,600 shares traded. Wall Street Analyst […]
Acasti Pharma Craig Hallum Acasti Pharma Inc Get Free Report Pharma Inc Acasti Pharma Daily

FSD Pharma Inc.: FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd in Acute Alcohol Intoxication

TORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech
United States Zeeshan Saeed Andrzej Chruscinski Scientific Affairs Pharma Inc Strategic Investments Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Initiates Coverage on MEI Pharma (NASDAQ:MEIP)

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report published on Thursday. The firm issued a buy rating on the stock. A number of other brokerages have also commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ rating in a report on […]
Stifel Nicolaus Pharma Inc Securities Exchange Commission Pharma Company Profile National Bank Free Report

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report released on Thursday. The brokerage issued a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus reiterated a hold rating and set a $7.00 price target on shares of MEI […]
Stifel Nicolaus National Bank Pharma Company Profile Securities Exchange Commission Pharma Inc Free Report

MEI Pharma (NASDAQ:MEIP) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note published on Thursday morning. The brokerage issued a buy rating on the stock. A number of other equities research analysts have also recently commented on MEIP. TheStreet cut shares of MEI Pharma from a c- rating to a d+ […]
Stifel Nicolaus Exchange Commission Pharma Company Profile National Bank Pharma Inc Free Report

Hookipa Pharma's (HOOK) "Outperform" Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Hookipa Pharma (NASDAQ:HOOK – Free Report) in a report published on Tuesday morning, Benzinga reports. The firm currently has a $5.00 price target on the stock. Separately, HC Wainwright reduced their target price on shares of Hookipa Pharma from $6.50 to $5.00 and set […]
Hookipa Pharma Securities Exchange Commission Royal Bank Hookipa Pharma Inc Pharma Inc Virtu Financial

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science